The Fragile X Clinic at CHOC will be devoted to the diagnosis, treatment, and study of the rare genetic condition of Fragile X syndrome.
First-of-its-kind study links mechanical bull riding with pediatric head injuries
A first-of-its-kind study by CHOC found that awareness and safety precautions are vital to prevent severe injuries from mechanic bull riding.
Device for patients with GI issues showing promise in treating Post-Concussion Syndrome
CHOC doctors discover the possible efficacy of treating PCS with the GI device IB-Stim. A clinical trial is underway.
CHOC leads 21-center study to find predictive biomarkers for infantile spasms, a rare and dangerous type of epileptic seizure
In a 21-center study, CHOC hopes to discover early treatment strategies for infantile spasms, a rare and dangerous type of epileptic seizure.
In the spotlight: Dr. John Crawford
Learn more about Dr. John Crawford, CHOC’s Medical Director of Neurology and Co-Medical Director of the CHOC Neuroscience Institute.
Neurologist to lead first-ever study of kids with Down syndrome to assess their likelihood of developing Alzheimer’s disease in adulthood
The study will examine biochemical markers in the blood of children with Down syndrome for a likelihood of them developing Alzheimer’s disease in adulthood.
